Therefore, given its plausible involvement in regulation of energy and glucose homeostasis and its dysregulation in obesity, TRPV1 may be a target for weight loss therapy and diabetes. The gene discussed is TRPV1; the disease is obesity due to melanocortin 4 receptor deficiency.